$-0.39 EPS Expected for T2 Biosystems, Inc. (TTOO); Man Group plc (LON:EMG) Had 10 Bulls

April 17, 2018 - By wolcottdaily

Man Group plc (LON:EMG) Logo

Among 18 analysts covering Man Group PLC (LON:EMG), 10 have Buy rating, 0 Sell and 8 Hold. Therefore 56% are positive. Man Group PLC had 176 analyst reports since July 24, 2015 according to SRatingsIntel. On Tuesday, January 24 the stock rating was maintained by Goldman Sachs with “Buy”. Liberum Capital maintained Man Group plc (LON:EMG) rating on Thursday, April 20. Liberum Capital has “Buy” rating and GBX 148 target. The stock has “Buy” rating by Shore Capital on Friday, October 13. Numis Securities maintained Man Group plc (LON:EMG) on Thursday, March 2 with “Hold” rating. As per Wednesday, February 17, the company rating was maintained by Barclays Capital. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, July 29. Numis Securities maintained the shares of EMG in report on Friday, November 27 with “Sell” rating. BNP Paribas maintained it with “Outperform” rating and GBX 135 target in Thursday, July 7 report. As per Tuesday, February 23, the company rating was initiated by UBS. The firm has “Buy” rating given on Thursday, October 15 by Shore Capital. See Man Group plc (LON:EMG) latest ratings:

12/04/2018 Broker: Numis Securities Rating: Hold Old Target: GBX 165.00 New Target: GBX 160.00 Maintain
12/04/2018 Broker: Shore Capital Rating: Buy New Target: GBX 175.50 Maintain
05/04/2018 Broker: BNP Paribas Rating: Outperform Old Target: GBX 160.00 New Target: GBX 190.00 Maintain
28/02/2018 Broker: Numis Securities Rating: Hold Old Target: GBX 189.00 New Target: GBX 189.00 Maintain
28/02/2018 Broker: Shore Capital Rating: Buy Maintain
28/02/2018 Broker: Liberum Capital Rating: Buy Maintain
22/02/2018 Broker: Morgan Stanley Rating: Equal Weight Old Target: GBX 149.00 New Target: GBX 223.00 Maintain
21/02/2018 Broker: Goldman Sachs Rating: Buy Old Target: GBX 182.00 New Target: GBX 210.00 Maintain
02/02/2018 Broker: Liberum Capital Rating: Buy Maintain
31/01/2018 Broker: Credit Suisse Rating: Outperform Old Target: GBX 195.00 New Target: GBX 243.00 Maintain

Analysts expect T2 Biosystems, Inc. (NASDAQ:TTOO) to report $-0.39 EPS on May, 1.They anticipate $0.09 EPS change or 18.75% from last quarter’s $-0.48 EPS. The stock decreased 1.45% or $0.1 during the last trading session, reaching $6.82. About 90,688 shares traded. T2 Biosystems, Inc. (NASDAQ:TTOO) has risen 12.64% since April 17, 2017 and is uptrending. It has outperformed by 1.09% the S&P500.

Man Group plc provides alternative investment management services worldwide. The company has market cap of 3.31 billion GBP. The firm offers a range of liquid investment products and solutions, which include quantitative and discretionary, long only and long short, and single and multi-manager. It has a 12.02 P/E ratio. It distributes its products and solutions directly to institutions; and to private investors through a network of intermediaries.

The stock decreased 0.68% or GBX 1.25 during the last trading session, reaching GBX 183.85. About 2.27 million shares traded. Man Group plc (LON:EMG) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 9 analysts covering T2 Biosystems Inc (NASDAQ:TTOO), 5 have Buy rating, 1 Sell and 3 Hold. Therefore 56% are positive. T2 Biosystems Inc had 23 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of T2 Biosystems, Inc. (NASDAQ:TTOO) earned “Buy” rating by Canaccord Genuity on Wednesday, March 7. The stock has “Buy” rating by H.C. Wainwright on Thursday, March 29. H.C. Wainwright maintained it with “Buy” rating and $8.0 target in Friday, November 3 report. The firm has “Market Perform” rating given on Thursday, November 10 by Leerink Swann. Cantor Fitzgerald maintained T2 Biosystems, Inc. (NASDAQ:TTOO) rating on Wednesday, November 2. Cantor Fitzgerald has “Buy” rating and $9 target. BTIG Research upgraded the shares of TTOO in report on Thursday, September 3 to “Buy” rating. The stock of T2 Biosystems, Inc. (NASDAQ:TTOO) has “Hold” rating given on Sunday, August 16 by BTIG Research. The stock of T2 Biosystems, Inc. (NASDAQ:TTOO) earned “Buy” rating by H.C. Wainwright on Monday, February 12. Canaccord Genuity initiated T2 Biosystems, Inc. (NASDAQ:TTOO) on Tuesday, October 27 with “Buy” rating. The firm has “Buy” rating given on Wednesday, March 7 by H.C. Wainwright.

T2 Biosystems, Inc. (NASDAQ:TTOO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 wolcottdaily

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts